The MBG Group departs as a 2009 KAIST Venture Company and is steadily working towards global bio companies for stable research and development and management innovation.

As a result of steadily practicing with the phrase "If you act with a vision, a miracle will happen", MBG in 2018 will achieve miraculous results.

MBG Group,

Research on Animal Cell Culture, New Treatment Agent for Atopic Diseases, Animal Experimentation for Breast Cancer Treatment and NK Cell are currently being conducted at MBG’s laboratory located in KAIST.

With 2030 visions of Nickel Plant, Biofloc Project, Mineral and LED Export Project, and Other Trading Projects, MBG will strive to become an enterprise that brings great happiness through changes for everyone.